Tezomin 2.5 mg Lyophilized Powder For Injection (IV/SC) Philippines - English - FDA (Food And Drug Administration)

tezomin 2.5 mg lyophilized powder for injection (iv/sc)

n/a; importer: qualimed pharma inc.; distributor: qualimed pharma inc. - bortezomib - lyophilized powder for injection (iv/sc) - 2.5 mg

Tezomin 3.5 mg Lyophilized Powder For Injection (IV,SC) Philippines - English - FDA (Food And Drug Administration)

tezomin 3.5 mg lyophilized powder for injection (iv,sc)

n/a; importer: qualimed pharma inc.; distributor: qualimed pharma inc. - bortezomib - lyophilized powder for injection (iv,sc) - 3.5 mg

Ifosmide-2000 2 g Powder For Injection (I.V.) Philippines - English - FDA (Food And Drug Administration)

ifosmide-2000 2 g powder for injection (i.v.)

ambica international corporation; distributor: qualimed pharma inc. - ifosfamide - powder for injection (i.v.) - 2 g

LIDOCAINE HYDROCHLORIDE solution United States - English - NLM (National Library of Medicine)

lidocaine hydrochloride solution

unit dose services - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - lidocaine hydrochloride oral topical solution usp, 2% (viscous) is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. it is also useful for reducing gagging during the taking of x-ray pictures and dental impressions. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of the solution.

OXYBUTYNIN CHLORIDE solution United States - English - NLM (National Library of Medicine)

oxybutynin chloride solution

atlantic biologicals corps - oxybutynin chloride (unii: l9f3d9renq) (oxybutynin - unii:k9p6mc7092) - oxybutynin chloride 5 mg in 5 ml - oxybutynin chloride syrup (oxybutynin chloride oral solution) is indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria). oxybutynin chloride is contraindicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions. oxybutynin chloride is also contraindicated in patients who have demonstrated hypersensitivity to the drug substance or other components of the product.

OXYBUTYNIN CHLORIDE solution United States - English - NLM (National Library of Medicine)

oxybutynin chloride solution

qualitest pharmaceuticals - oxybutynin chloride (unii: l9f3d9renq) (oxybutynin - unii:k9p6mc7092) - oxybutynin chloride 5 mg in 5 ml

LEVETIRACETAM- levetiracetam solution United States - English - NLM (National Library of Medicine)

levetiracetam- levetiracetam solution

par pharmaceutical - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 100 mg in 1 ml - levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. none. levetiracetam blood levels may decrease during pregnancy [see warnings and precautions (5.9) ]. pregnancy category c there are no adequate and controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam should be used during pregnancy only if the potential benefit just

IOPHEN DM NR dextromethorphan and guaifenesin solution United States - English - NLM (National Library of Medicine)

iophen dm nr dextromethorphan and guaifenesin solution

qualitest pharmaceuticals - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - dextromethorphan hydrobromide 10 mg in 5 ml

QDRYL ALLERGY- diphenhydramine hydrochloride solution United States - English - NLM (National Library of Medicine)

qdryl allergy- diphenhydramine hydrochloride solution

qualitest pharmaceuticals - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 12.5 mg in 5 ml - antihistamine - temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing runny nose itchy, watery eyes itching of the nose or throat - sneezing - runny nose - itchy, watery eyes - itching of the nose or throat - to make a child sleepy - with any other product containing diphenhydramine, even one used on skin - glaucoma - trouble urinating due to an enlarged prostate gland - a breathing problem such as emphysema or chronic bronchitis

QTUSSIN guaifenesin solution United States - English - NLM (National Library of Medicine)

qtussin guaifenesin solution

qualitest pharmaceuticals - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - guaifenesin 100 mg in 5 ml